About Relay Therapeutics, Inc. (RLAY) ; Yesterday's range. $ - $ ; Debt / equity. x ; 52 week range. $ - $ ; 5 year debt / equity. x ; Beta . Latest After-Hours Trades -> ; After Hours Time (ET). After Hours Price. After Hours Share Volume ; $ ; $ ; $ Stock analysis for Relay Therapeutics Inc (RLAY:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company. Discover historical prices for RLAY stock on Yahoo Finance. View daily, weekly or monthly format back to when Relay Therapeutics, Inc. stock was issued. RLAY / Relay Therapeutics, Inc. (NasdaqGM) - Forecast, Price Target, Estimates, Predictions.
Get the latest Relay Therapeutics Inc. (RLAY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. RLAY | Complete Relay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. PROFILE (RLAY). Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic. The 6 analysts with month price forecasts for Relay Therapeutics stock have an average target of , with a low estimate of 14 and a high estimate of Recursion Pharmaceuticals Inc. $ RXRX % ; Absci Corp. $ ABSI % ; Vertex Pharmaceuticals Incorporated. $ VRTX %. Get Relay Therapeutics Inc (RLAY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Relay Therapeutics market cap history and chart from to stock price by the number of shares outstanding. Relay Therapeutics market. Relay Therapeutics, Inc.'s stock symbol is RLAY and currently trades under NASDAQ. It's current price per share is approximately $ Investors & Media · Stock Quote & Chart · Investment Calculator · Analyst Coverage.
Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 21 Aug, Find the latest Relay Therapeutics, Inc. (RLAY) stock quote, history, news Price/Sales (ttm). Price/Book (mrq). Enterprise Value/Revenue. Based on 8 Wall Street analysts offering 12 month price targets for Relay Therapeutics in the last 3 months. The average price target is $ with a high. Latest news: Relay Therapeutics, Inc. · JMP Securities Cuts Price Target on Relay Therapeutics to $21 From $24, Maintains Market Outperform Rating · HC Wainwright. Common Stock (RLAY). 1D. 5D. Relay Therapeutics Inc ; Previous Close: ; Volume: ; 3 Month Average Trading Volume: ; Shares Out (Mil): ; Market Cap: Relay Therapeutics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range - 52 Wk Range - View Relay Therapeutics, Inc. RLAY stock quote prices, financial information, real-time forecasts, and company news from CNN. Relay Therapeutics (RLAY) has a Smart Score of 3 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund.
According to 5 Wall Street analysts that have issued a 1 year RLAY price target, the average RLAY price target is $, with the highest RLAY stock price. 28 minutes ago. Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates. Relay Therapeutics (RLAY) delivered earnings and revenue surprises of % and. Relay Therapeutics (RLAY) has a market cap of $M as of August 18, What is the P/E ratio for Relay Therapeutics stock? Relay Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RLAY. The last closing price for Relay Therapeutics was.